Highlights and Quick Summary
- Net Profit Margin for the quarter ending March 31, 2022 was -1663.57% (a 105.25% increase compared to previous quarter)
- Year-over-year quarterly Net Profit Margin increased by 16.59%
- Annual Net Profit Margin for 2021 was -977.02% (a -33.36% decrease from previous year)
- Annual Net Profit Margin for 2020 was -1466.01% (a -12.7% decrease from previous year)
- Annual Net Profit Margin for 2019 was -1679.29% (a -72.8% decrease from previous year)
- Twelve month Net Profit Margin ending March 31, 2022 was -1215.58% (a 24.6% increase compared to previous quarter)
- Twelve month trailing Net Profit Margin increased by 4.9% year-over-year
Trailing Net Profit Margin for the last four month:
| 31 Mar '22 | 31 Dec '21 | 30 Sep '21 | 30 Jun '21 |
|---|---|---|---|
| -1215.58% | -975.62% | -1003.25% | -1158.79% |
Visit stockrow.com/NVCN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Profit Margin of Neovasc Inc.
Most recent Net Profit Marginof NVCN including historical data for past 10 years.Interactive Chart of Net Profit Margin of Neovasc Inc.
Neovasc Inc. Net Profit Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -1663.57% | – | – | – | – |
| 2021 | -810.5% | -1071.23% | -1426.82% | -479.72% | -977.02% |
| 2020 | -860.56% | -1633.89% | -3494.82% | -771.55% | -1466.01% |
| 2019 | -2183.49% | -1239.16% | -1809.39% | -1470.71% | -1679.29% |
| 2018 | 2231.45% | -3046.14% | -12128.73% | -16440.31% | -6173.64% |
| 2017 | -409.46% | -341.55% | -409.26% | -529.57% | -425.1% |
| 2016 | 1347.79% | -960.29% | -4891.72% | -542.24% | -909.25% |
| 2015 | -332.01% | -308.6% | -230.66% | -215.26% | -269.19% |
| 2014 | -227.28% | -107.48% | -146.93% | -9.91% | -119.52% |
| 2013 | -66.8% | -39.62% | -44.36% | -92.53% | -57.41% |
| 2012 | 147.51% | -60.15% | -92.77% | -73.86% | -4.48% |
| 2011 | -54.99% | – | – | – | -73.52% |
Business Profile of Neovasc Inc.
Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.